Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Journal of Neuroimmunology
|
August 5, 2008
The MGTX experience: challenges in planning and executing an international, multicenter clinical trial
Inmaculada B Aban, Gil I Wolfe, Gary R Cutter, et al.
Archives of Neurology
|
September 17, 2003
Challenges in the identification of cobalamin-deficiency polyneuropathy
David S Saperstein, Gil I Wolfe, Gary S Gronseth, et al.
Neurology
|
November 24, 2020
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, et al.
Therapeutic Advances in Neurological Disorders
|
August 6, 2025
National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel
Shahar Shelly, Marc Gotkine, Adi Wilf Yarkoni, et al.
Frontiers in Public Health
|
May 12, 2025
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
Sarah Dewilde, Cynthia Z Qi, Femke De Ruyck, et al.
Muscle & Nerve
|
January 5, 2006
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis
Shin J Oh, Yuki Hatanaka, Shoji Hemmi, et al.
JAMA Network Open
|
April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis
Joseph Lord, Matthew Walton, Peter Murphy, et al.
JAMA Neurology
|
February 15, 2013
Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample
Robert W Haley, Elizabeth Charuvastra, William E Shell, et al.
Muscle & Nerve
|
July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial
Michael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Muscle & Nerve
|
September 22, 2025
Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PIS
Katherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Journal of Neuroimmunology
|
August 5, 2008
The MGTX experience: challenges in planning and executing an international, multicenter clinical trial
Inmaculada B Aban, Gil I Wolfe, Gary R Cutter, et al.
Archives of Neurology
|
September 17, 2003
Challenges in the identification of cobalamin-deficiency polyneuropathy
David S Saperstein, Gil I Wolfe, Gary S Gronseth, et al.
Neurology
|
November 24, 2020
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, et al.
Therapeutic Advances in Neurological Disorders
|
August 6, 2025
National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel
Shahar Shelly, Marc Gotkine, Adi Wilf Yarkoni, et al.
Frontiers in Public Health
|
May 12, 2025
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
Sarah Dewilde, Cynthia Z Qi, Femke De Ruyck, et al.
Muscle & Nerve
|
January 5, 2006
Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis
Shin J Oh, Yuki Hatanaka, Shoji Hemmi, et al.
JAMA Network Open
|
April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis
Joseph Lord, Matthew Walton, Peter Murphy, et al.
JAMA Neurology
|
February 15, 2013
Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample
Robert W Haley, Elizabeth Charuvastra, William E Shell, et al.
Muscle & Nerve
|
July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial
Michael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Muscle & Nerve
|
September 22, 2025
Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PIS
Katherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Page
of 11